8-K filings / November 20, 2026
Phio Pharmaceuticals Corp.: A stock exchange listing notice
Phio Pharmaceuticals Corp. filed a current report (Form 8-K) with the SEC on November 20, 2026. It reports a stock exchange listing notice.
Item 3.01
Stock exchange listing notice
-
Exchange
Nasdaq
From the filing
Source
“On November 16, 2026, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying that the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the $1.00 per share minimum required pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).”
Read by code from this sentence of the filing. -
What it says
The company does not meet a listing rule
From the filing
Source
“On November 16, 2026, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying that the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the $1.00 per share minimum required pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).”
Read by code from this sentence of the filing. -
Rule cited
Nasdaq Listing Rule 5550(a)(2)
From the filing
Source
“On November 16, 2026, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying that the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the $1.00 per share minimum required pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).”
Read by code from this sentence of the filing. -
Notice date
November 16, 2026
From the filing
Source
“On November 16, 2026, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying that the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the $1.00 per share minimum required pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.